Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101,960,784
-
Total 13F shares
-
43,302,427
-
Share change
-
+1,822,197
-
Total reported value
-
$429,553,897
-
Price per share
-
$9.92
-
Number of holders
-
66
-
Value change
-
+$13,144,675
-
Number of buys
-
38
-
Number of sells
-
21
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q1 2022
As of 31 Mar 2022,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,302,427 shares.
The largest 10 holders included
Canaan Partners XI LLC, Atlas Venture Life Science Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, BOXER CAPITAL, LLC, and BlackRock Inc..
This page lists
66
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.